SEATTLE, Jan. 12 /PRNewswire/ -- The Washington Biotechnology & Biomedical Association (WBBA), in collaboration with BC Biotech, BC MedTech, BioAlberta, Idaho Bioscience Association, Montana BioScience Alliance and the Oregon Bioscience Association, announced that 60 Pacific Northwest life science companies have been selected to present at Invest Northwest 2006.
Invest Northwest 2006, to be held March 21 and 22 in Seattle, is a forum for venture capitalists, analysts, investment bankers, institutional investors, pension fund managers, and pharmaceutical and biotech corporate partners to meet CEOs and senior executives from selected life science companies based in the Pacific Northwest. The following companies will present at Invest Northwest. Public companies are indicated by ticker symbol.
Presenting Companies, Invest Northwest 2006 -- Accium BioSciences Inc. - Seattle, WA -- Acucela Inc. - Seattle, WA -- Alder Biotherapeutics - Bothell, WA -- Allon Therapeutics - Vancouver, BC -- AMES Technology - Portland, OR -- Angiotech Pharmaceuticals - Vancouver, BC -- AnorMED Inc. - Langley, BC -- ARC Pharmaceuticals Inc. - Vancouver, BC -- Aspreva Pharmaceuticals - Victoria, BC -- Calypso Medical Technologies - Seattle, WA -- Cardiac Science - Bothell, WA -- CardioMetrix - Bothell, WA -- Cell Therapeutics Inc. - Seattle, WA -- Chemokine Therapeutics Corp. - Vancouver, BC -- CombiMatrix Corporation - Mukilteo, WA -- CompleGen - Seattle, WA -- Corus Pharma Inc. - Seattle, WA -- Dendreon Corporation - Seattle, WA -- enGene Inc. - Vancouver, BC -- Epigenomics AG - Berlin, Germany -- GenoLogics Life Sciences - Victoria, BC -- Hemcon, Inc. - Portland, OR -- iCo Therapeutics Inc. - Vancouver, BC -- ICOS Corporation - Bothell, WA -- Ikaria Inc. - Seattle, WA -- Illumigen Biosciences Inc. - Seattle WA -- Inflazyme Pharmaceuticals Ltd. - Richmond, BC -- Inimex Pharmaceuticals Inc. - Vancouver, BC -- Inovise Medical Inc. - Portland, OR -- Koronis Pharmaceuticals - Seattle, WA -- Light Sciences Corporation - Snoqualmie, WA -- LigoCyte Pharmaceuticals, Inc. - Bozeman, MT -- LipoSonix Inc. - Bothell, WA -- Micronics - Redmond, WA -- MIGENIX - Vancouver, BC -- Nastech Pharmaceutical Company - Bothell, WA -- Neurocom International Inc. - Clackamas, OR -- NeuroMed Technologies Inc. - Vancouver, BC -- Nura Inc. - Seattle, WA -- OncoGenex Technologies Inc. - Vancouver, BC -- Oncolytics Biotech Inc. - Calgary, AB -- Pathway Medical Technologies Inc. - Redmond, WA -- PriTest Inc. - Redmond, WA -- Protox Therapies Inc. - Vancouver, BC -- Response Biomedical Corporation - Burnaby, BC -- SCOLR Pharma, Inc. - Bellevue, WA -- Seattle Genetics Inc. - Bothell, WA -- SonoSite - Bothell, WA -- Sonus Pharmaceuticals Inc. - Bothell, WA -- Sound Pharmaceuticals - Seattle, WA -- Spiration Inc. - Redmond, WA -- Targeted Genetics Corporation - Seattle, WA -- Trubion Pharmaceuticals Inc. - Seattle, WA -- Twinstrand Therapeutics Inc. - Burnaby, BC -- VisionGate Inc. - Gig Harbor, WA -- VizX Labs LLC - Seattle, WA -- VSM MedTech Ltd. - Coquitlam, BC -- Xenon Pharmaceuticals Inc. - Burnaby, BC -- Xillix Technologies Corp. - Richmond, BC -- ZymoGenetics Inc. - Seattle, WA
To register for Invest Northwest 2006, please visit www.washbio.org or call WBBA at (206) 624-1967 for details.
About the WBBA
Based in Seattle, the Washington Biotechnology & Biomedical Association (WBBA) is a not-for-profit association of Washington state-based biotechnology and medical device companies, research institutions and related organizations. WBBA is working with leaders across the state on a comprehensive bioscience strategy for Washington’s future.
For further information, contact: Washington Biotechnology & Biomedical Association Pam Love (206) 624-1967 pamlove@washbio.org
Washington Biotechnology & Biomedical Association (WBBA)
CONTACT: Pam Love of Washington Biotechnology & Biomedical Association,+1-206-624-1967, or pamlove@washbio.org